Clinical Trials Directory

Trials / Conditions / Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

11 registered clinical trials studyying Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingSintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell
NCT06583083
Sun Yat-sen UniversityPhase 2
RecruitingLinperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
NCT06376721
Beijing Tongren HospitalPhase 1 / Phase 2
RecruitingScreening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
NCT06314334
Fudan UniversityPhase 2
CompletedTislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma
NCT05058755
Xinhua Hospital, Shanghai Jiao Tong University School of MedicineN/A
UnknownCamrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL
NCT04366128
Rong TaoN/A
UnknownSintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma
NCT04004572
Rong TaoPhase 2
CompletedCombined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma
NCT03936452
Sun Yat-sen UniversityPhase 2
UnknownMaintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma
NCT03630731
Chinese Academy of Medical SciencesPhase 2
CompletedAnlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma
NCT03618238
Xinhua Hospital, Shanghai Jiao Tong University School of MedicinePhase 2
UnknownSIMPLE Chemotherapy for NK Lymphoma/Leukaemia
NCT03623087
The University of Hong KongPhase 3
UnknownTreatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma
NCT03107962
Mingzhi ZhangPhase 2